Basic Information
| RNALocate ID: | RLID:01001564 |
| RNA Symbol: | hsa-miR-199a-5p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-199a-5p |
| RNA ID: | miRBase:MIMAT0000231 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 27563705 |
| Tissue/Cell Line: | Skeletal muscle cells |
| Method: | miRNA assay|qRT-PCR |
| Description: | Although miRNAs are mainly located in the cytosol or the nucleus, a subset of ~150 different miRNAs, called mitomiRs, has also been found localized to mitochondrial fractions of cells and tissues together with the subunits of the RNA-induced silencing complex (RISC). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001563 | Mitochondrion | Myotube | 27396686 |
| RLID:01001565 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11001283 | Exosome | Brain tissue | 23382797 |
| RLID:11001284 | Exosome | Plasma | 23663360 |
| RLID:11001285 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID-D:11000307 | Microvesicle | Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001164 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-199a-5p | Idiopathic pulmonary fibrosis | MNDR-E-MI-24809 |
| MNDR | hsa-miR-199a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-24810 |
| MNDR | hsa-miR-199a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-24811 |
| MNDR | hsa-miR-199a-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-24812 |
| MNDR | hsa-miR-199a-5p | Oral squamous cell carcinoma | MNDR-E-MI-24813 |
| MNDR | hsa-miR-199a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-24814 |
| MNDR | hsa-miR-199a-5p | Medulloblastoma | MNDR-E-MI-24815 |
| MNDR | hsa-miR-199a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-24816 |
| MNDR | hsa-miR-199a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-24817 |
| MNDR | hsa-miR-199a-5p | Lymphoma | MNDR-E-MI-24818 |
| MNDR | hsa-miR-199a-5p | Lymphoma non-hodgkin | MNDR-E-MI-24819 |
| MNDR | hsa-miR-199a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-24820 |
| MNDR | hsa-miR-199a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-24821 |
| MNDR | hsa-miR-199a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-24822 |
| MNDR | hsa-miR-199a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-24823 |
| MNDR | hsa-miR-199a-5p | Breast cancer luminal | MNDR-E-MI-24824 |
| MNDR | hsa-miR-199a-5p | Niemann-pick disease type c | MNDR-E-MI-24825 |
| MNDR | hsa-miR-199a-5p | Miyoshi myopathy | MNDR-E-MI-24826 |
| MNDR | hsa-miR-199a-5p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-24827 |
| MNDR | hsa-miR-199a-5p | Dermatomyositis | MNDR-E-MI-24828 |
| MNDR | hsa-miR-199a-5p | Prostate cancer | MNDR-E-MI-24829 |
| MNDR | hsa-miR-199a-5p | Gastric cancer | MNDR-E-MI-24830 |
| MNDR | hsa-miR-199a-5p | Gastric lymphoma | MNDR-E-MI-24831 |
| MNDR | hsa-miR-199a-5p | Alzheimer disease | MNDR-E-MI-24832 |
| MNDR | hsa-miR-199a-5p | Bladder cancer | MNDR-E-MI-24833 |
| MNDR | hsa-miR-199a-5p | Dysautonomia familial | MNDR-E-MI-24834 |
| MNDR | hsa-miR-199a-5p | Distal muscular dystrophy | MNDR-E-MI-24835 |
| MNDR | hsa-miR-199a-5p | Duchenne muscular dystrophy | MNDR-E-MI-24836 |
| MNDR | hsa-miR-199a-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-24837 |
| MNDR | hsa-miR-199a-5p | Leukemia | MNDR-E-MI-24838 |
| MNDR | hsa-miR-199a-5p | Ataxia telangiectasia | MNDR-E-MI-24839 |
| MNDR | hsa-miR-199a-5p | Huntington disease | MNDR-E-MI-24840 |
| MNDR | hsa-miR-199a-5p | Chorea | MNDR-E-MI-24841 |
| MNDR | hsa-miR-199a-5p | Cardiovascular disease | MNDR-E-MI-24842 |
| MNDR | hsa-miR-199a-5p | Carotid stenosis | MNDR-E-MI-24843 |
| MNDR | hsa-miR-199a-5p | Lung cancer | MNDR-E-MI-24844 |
| MNDR | hsa-miR-199a-5p | Parkinson disease | MNDR-E-MI-24845 |
| MNDR | hsa-miR-199a-5p | Niemann-pick disease | MNDR-E-MI-24846 |
| MNDR | hsa-miR-199a-5p | Colonic adenomas | MNDR-E-MI-24847 |
| MNDR | hsa-miR-199a-5p | Breast cancer | MNDR-E-MI-24848 |
| MNDR | hsa-miR-199a-5p | Cancer | MNDR-E-MI-24849 |
| MNDR | hsa-miR-199a-5p | Neuroendocrine neoplasia | MNDR-E-MI-24850 |
| MNDR | hsa-miR-199a-5p | Invasive squamous cell carcinomas | MNDR-E-MI-24851 |
| MNDR | hsa-miR-199a-5p | Thyroid cancer | MNDR-E-MI-24852 |
| MNDR | hsa-miR-199a-5p | Pancreatic cancer | MNDR-E-MI-24853 |
| MNDR | hsa-miR-199a-5p | Melanoma | MNDR-E-MI-24854 |
| MNDR | hsa-miR-199a-5p | Epithelial ovarian cancer | MNDR-E-MI-24855 |
| MNDR | hsa-miR-199a-5p | Colon cancer | MNDR-E-MI-24856 |
| MNDR | hsa-miR-199a-5p | Colon adenocarcinoma | MNDR-E-MI-24857 |
| MNDR | hsa-miR-199a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-24858 |
| MNDR | hsa-miR-199a-5p | Ovarian cancer | MNDR-E-MI-24859 |
| MNDR | hsa-miR-199a-5p | Prostate adenocarcinoma | MNDR-E-MI-24860 |
| MNDR | hsa-miR-199a-5p | Kidney cancer | MNDR-E-MI-24861 |
| MNDR | hsa-miR-199a-5p | Endometriosis | MNDR-E-MI-24862 |
| MNDR | hsa-miR-199a-5p | Testicular cancer | MNDR-E-MI-24863 |
| MNDR | hsa-miR-199a-5p | Carcinoma ductal breast | MNDR-E-MI-24864 |
| MNDR | hsa-miR-199a-5p | Glioblastoma | MNDR-E-MI-24865 |
| MNDR | hsa-miR-199a-5p | Glioma | MNDR-E-MI-24866 |
| MNDR | hsa-miR-199a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-24867 |
| MNDR | hsa-miR-199a-5p | Nemaline myopathy | MNDR-E-MI-24868 |
| MNDR | hsa-miR-199a-5p | Central nervous system lymphoma | MNDR-E-MI-24869 |
| MNDR | hsa-miR-199a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-24870 |
| MNDR | hsa-miR-199a-5p | Epilepsy temporal lobe | MNDR-E-MI-24871 |
| MNDR | hsa-miR-199a-5p | Osteosarcoma | MNDR-E-MI-24872 |
| MNDR | hsa-miR-199a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-24873 |
| MNDR | hsa-miR-199a-5p | Meningioma | MNDR-E-MI-24874 |
| MNDR | hsa-miR-199a-5p | Uterine cancer | MNDR-E-MI-24875 |
| MNDR | hsa-miR-199a-5p | Cervical adenocarcinoma | MNDR-E-MI-24876 |
| MNDR | hsa-miR-199a-5p | Gastric adenocarcinoma | MNDR-E-MI-24877 |
| MNDR | hsa-miR-199a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-24878 |
| MNDR | hsa-miR-199a-5p | Lung squamous cell carcinoma | MNDR-E-MI-24879 |
| MNDR | hsa-miR-199a-5p | Carcinoma lung non-small-cell | MNDR-E-MI-24880 |
| MNDR | hsa-miR-199a-5p | Lung adenocarcinoma | MNDR-E-MI-24881 |
| MNDR | hsa-miR-199a-5p | Adrenocortical cancer | MNDR-E-MI-24882 |
| MNDR | hsa-miR-199a-5p | Thyroid carcinoma | MNDR-E-MI-24883 |
| MNDR | hsa-miR-199a-5p | Papillary thyroid carcinoma | MNDR-E-MI-24884 |
| MNDR | hsa-miR-199a-5p | Ovarian carcinoma | MNDR-E-MI-24885 |
| MNDR | hsa-miR-199a-5p | Bladder urothelial carcinoma | MNDR-E-MI-24886 |
| MNDR | hsa-miR-199a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-24887 |
| MNDR | hsa-miR-199a-5p | Liver disease | MNDR-E-MI-24888 |
| MNDR | hsa-miR-199a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-24889 |
| MNDR | hsa-miR-199a-5p | Carcinoma renal cell | MNDR-E-MI-24890 |
| MNDR | hsa-miR-199a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-24891 |
| MNDR | hsa-miR-199a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-24892 |
| MNDR | hsa-miR-199a-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-24893 |
| MNDR | hsa-miR-199a-5p | Adenocarcinoma of esophagus | MNDR-E-MI-24894 |
| MNDR | hsa-miR-199a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-24895 |
| MNDR | hsa-miR-199a-5p | Cholangiocarcinoma | MNDR-E-MI-24896 |
| MNDR | hsa-miR-199a-5p | Esophageal cancer | MNDR-E-MI-24897 |
| MNDR | hsa-miR-199a-5p | Oncocytoma | MNDR-E-MI-24898 |
| MNDR | hsa-miR-199a-5p | Lung small cell carcinoma | MNDR-E-MI-24899 |
| MNDR | hsa-miR-199a-5p | Synovial sarcoma | MNDR-E-MI-24900 |
| MNDR | hsa-miR-199a-5p | Gastric carcinoma | MNDR-E-MI-24901 |
| MNDR | hsa-miR-199a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-24902 |
| MNDR | hsa-miR-199a-5p | Heart failure | MNDR-E-MI-24903 |
| MNDR | hsa-miR-199a-5p | Uveal melanoma | MNDR-E-MI-24904 |
| MNDR | hsa-miR-199a-5p | Fibromyalgia | MNDR-E-MI-24905 |
| MNDR | hsa-miR-199a-5p | Encephalomyelitis | MNDR-E-MI-24906 |
| MNDR | hsa-miR-199a-5p | Breast invasive carcinoma | MNDR-E-MI-24907 |
| MNDR | hsa-miR-199a-5p | Hepatocellular carcinoma | MNDR-E-MI-24908 |
| MNDR | hsa-miR-199a-5p | B-cell lymphoma | MNDR-E-MI-24909 |
| MNDR | hsa-miR-199a-5p | Rheumatoid arthritis | MNDR-E-MI-24910 |
| MNDR | hsa-miR-199a-5p | T-cell leukemia | MNDR-E-MI-24911 |
| MNDR | hsa-miR-199a-5p | Periodontitis | MNDR-E-MI-24912 |
| MNDR | hsa-miR-199a-5p | Hodgkin lymphoma | MNDR-E-MI-24913 |
| MNDR | hsa-miR-199a-5p | Ulcerative colitis | MNDR-E-MI-24914 |
| MNDR | hsa-miR-199a-5p | Burkitt lymphoma | MNDR-E-MI-24915 |
| MNDR | hsa-miR-199a-5p | Tonsil cancer | MNDR-E-MI-24916 |
| MNDR | hsa-miR-199a-5p | Acute myelocytic leukemia | MNDR-E-MI-24917 |
| MNDR | hsa-miR-199a-5p | Colorectal cancer | MNDR-E-MI-24918 |
| MNDR | hsa-miR-199a-5p | Nasopharynx carcinoma | MNDR-E-MI-24919 |
| MNDR | hsa-miR-199a-5p | Multiple myeloma | MNDR-E-MI-24920 |
| MNDR | hsa-miR-199a-5p | Ovarian epithelial cancer | MNDR-E-MI-24921 |
| MNDR | hsa-miR-199a-5p | Cardiac hypertrophy | MNDR-E-MI-24922 |
| MNDR | hsa-miR-199a-5p | Nasopharyngeal cancer | MNDR-E-MI-24923 |
| MNDR | hsa-miR-199a-5p | Prostatic neoplasms | MNDR-E-MI-24924 |
| MNDR | hsa-miR-199a-5p | Polymyositis | MNDR-E-MI-24925 |
| MNDR | hsa-miR-199a-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-24926 |
| MNDR | hsa-miR-199a-5p | Pancreatitis chronic | MNDR-E-MI-24927 |
| MNDR | hsa-miR-199a-5p | Visceral pain | MNDR-E-MI-24928 |
| MNDR | hsa-miR-199a-5p | Stroke lacunar | MNDR-E-MI-24929 |
| MNDR | hsa-miR-199a-5p | Breast cancer her3+ negative | MNDR-E-MI-24930 |
| MNDR | hsa-miR-199a-5p | Limb-girdle muscular dystrophies types 2A | MNDR-E-MI-24931 |
| MNDR | hsa-miR-199a-5p | Low grade dysplastic nodule | MNDR-E-MI-24932 |
| MNDR | hsa-miR-199a-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-24933 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CT70 | Homo sapiens | RR00009736 |
TOP